Market Access News | pharmaphorum

News

Trump sets course for 100%, then 200%, tariffs on generics

Trump has said he intends to impose tariffs of 100% on generic drugs imported into the US from 2028, rising to 200% after a year, in a reshoring push.

News

MSD gets first FDA okay for oral PCSK9 cholesterol drug

MSD has won the race to bring an oral PCSK9 inhibitor through to regulatory approval for LDL cholesterol-lowering in the US.

News

Bayer's Kerendia on course for NHS use in heart failure

Up to 280,000 people with heart failure could soon be eligible for NHS treatment with Bayer's Kerendia, following new NICE guidance.

News

Novo's Wegovy pill cleared for weight loss in EU

The EU has approved Novo Nordisk's pill formulation of weight-loss therapy Wegovy, keeping the company a step ahead of arch rival Eli Lilly.

News

Celcuity gets FDA nod for first-in-class breast cancer drug

Celcuity has won FDA approval for gedatolisib – its first product – as a treatment for patients with a particular form of breast cancer.

News

FDA clears at-home start dose for Alzheimer's drug Leqembi

The FDA has cleared Eisai and Biogen's Leqembi Iqlik subcutaneous injection as a starting dose, removing the need for regular infusion clinic visits.

Trump sets course for 100%, then 200%, tariffs on generics

MSD gets first FDA okay for oral PCSK9 cholesterol drug

Bayer's Kerendia on course for NHS use in heart failure

Novo's Wegovy pill cleared for weight loss in EU

Celcuity gets FDA nod for first-in-class breast cancer drug

FDA clears at-home start dose for Alzheimer's drug Leqembi

Pharvaris plans filings for HAE drug after pivotal trial win

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks